GSK plc
GSK
$40.32
$0.270.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 802.46% | -105.10% | 11.56% | 205.08% | -76.55% |
| Total Depreciation and Amortization | -79.20% | 53.52% | 15.79% | 33.44% | -28.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 584.01% | -10.27% | -1,150.18% | -106.08% | 655.58% |
| Change in Net Operating Assets | -128.33% | 633.08% | 47.23% | -136.05% | 553.67% |
| Cash from Operations | 6.41% | 99.64% | 15.58% | -69.40% | 41.75% |
| Capital Expenditure | -75.53% | -4.18% | -21.15% | 47.91% | -59.47% |
| Sale of Property, Plant, and Equipment | 5,903.24% | -48.42% | 98.97% | -85.42% | -37.57% |
| Cash Acquisitions | -1,499.22% | 87.50% | 95.45% | -36,752.70% | 96.89% |
| Divestitures | -64.02% | 55.79% | -132.13% | 56.25% | -243.37% |
| Other Investing Activities | -32.62% | -139.03% | 34.18% | 11.13% | 637.46% |
| Cash from Investing | -50.65% | -197.93% | 614.11% | -156.76% | 153.55% |
| Total Debt Issued | -- | -- | -- | -- | -129.11% |
| Total Debt Repaid | -90.89% | -1.34% | -56.84% | 73.05% | -191.93% |
| Issuance of Common Stock | -100.00% | 0.00% | -94.44% | 1,700.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.59% | 3.17% | -14.20% | -2.08% | 1.72% |
| Other Financing Activities | -1,572.00% | 92.58% | -159.23% | 36.89% | -112.37% |
| Cash from Financing | 33.17% | 19.25% | -48.66% | 69.88% | -100.00% |
| Foreign Exchange rate Adjustments | 120.26% | -338.41% | 58.11% | 42.95% | -245.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.68% | -47.18% | 207.22% | -70.14% | -782.98% |
